The Engine Releases 2021 Tough Tech Landscape Report Detailing Record Venture Investment In Climate Change, Human Health, And Advanced Systems & Infrastructure Startups
Oct 21, 2021
The Engine, the venture firm spun out of MIT that invests in early-stage Tough Tech companies solving the world’s most urgent problems, released its report, 2021 Tough Tech Landscape, with data provided by PitchBook, the premier data provider for the private and public equity markets.
NVE: Fiscal Q2 Earnings Snapshot
Oct. 20, 2021
EDEN PRAIRIE, Minn. (AP) _ NVE Corp. (NVEC) on Wednesday reported fiscal second-quarter net income of $3.6 million.
On a per-share basis, the Eden Prairie, Minnesota-based company said it had net income of 75 cents.
Angeles Equity Partners Completes Sale of APCT
Oct 06, 2021
Angeles Equity Partners, LLC (“Angeles”), a private investment firm focused on value creation through operational transformation, announced the sale of APCT, Inc. (“APCT”) to an affiliate of Industrial Growth Partners (“IGP”). APCT is an integrated manufacturer of complex, quick-turn printed circuit board (“PCB”) prototypes headquartered in Silicon Valley.
ZEN Graphene Solutions Highlights Results of Annual Shareholder Meeting
Oct 4, 2021
ZEN Graphene Solutions Ltd., a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces that shareholders have approved all resolutions put forward at the annual shareholder meeting held on September 27, 2021. These resolutions include several initiatives to better align the company's classifications and communications with its value proposition in nanotechnology and health sciences.
Strathclyde to establish nanotechnologies facility
Oct 1, 2021
Strathclyde University has been awarded £853,000 to host a bespoke nationwide facility for testing nanotechnologies for healthcare applications.
The Multiscale Metrology Suite (MMS) for Next-Generation Health Nanotechnologies will provide UK scientists with access to technology for the analysis of materials, supporting discovery of future diagnostics and therapies.
Fujifilm establishes the Advanced Materials Strategy Headquarters
Sep 30, 2021
FUJIFILM Corporation (President and CEO, Representative Director Teiichi Goto) today announced the establishment of the Advanced Materials Strategy Headquarters on October 1, 2021 to further accelerate business growth in the field of advanced materials including semiconductor materials and display materials.
Nanowear Receives FDA 510(k) Platform Clearance to Implement Forthcoming AI-based Diagnostics in its Closed Loop Hospital-at-Home Network
Sep 28, 2021
Nanowear, a leading hospital-at-home and remote diagnostic platform informed by proprietary cloth nanotechnology and AI, today announced that it received its third FDA 510(k) clearance and first software-only clearance as an end-to-end digital platform, illustrating unique capabilities available to enterprise customer channels across a broad spectrum of diagnostic and monitoring verticals.
UK-wide facility to test for future health nanotechnologies
Sep 28, 2021
The University has been awarded £853,000 by the EPSRC (Engineering and Physical Sciences Research Council) to create the Multiscale Metrology Suite (MMS) for Next-Generation Health Nanotechnologies.
Nanovis Announces Alpha Launch of the First and Only Bioceramic Nanotube-Enhanced Pedicle Screw System, Nano FortiFix
Sep 28, 2021
Nanovis, an award winning technology company with unique and differentiated nanotechnology surfaces for improving bone growth and fighting infection, is pleased to announce the first implantations of its Bioceramic Nanotube-Enhanced pedicle screw system, Nano FortiFix, the only nanotechnology designated titanium-surfaced pedicle screw.
GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021
Sep 23, 2021
The funding will support the further development of GenEdit’s NanoGalaxyTM platform of non-viral, non-lipid polymer nanoparticles, and the selection for clinical development of therapeutic candidates targeting diseases of the nervous system.
OncoNano raised $50 million in Series B funding in June.
Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology.
NBA's Kevin Love, To Promote Mental Health, Invests in Air Purifier Molekule
Sep 17, 2021
Molekule’s devices use nanotechnology to attack pollutants at their molecular level. The FDA has classified Molekule’s air filters as Class II medical devices for their ability to kill airborne bacteria and viruses. Love, who has spoken openly about his struggles with anxiety and depression in the past, said in a statement that studies linking air pollution to mental illness helped attract him to Molekule.